Page 34 - SaxoCell Annual Report 2021
P. 34
UltraCART
The UltraCAR-T project is dedicated to the core topic of cellular immunotherapy with
genetically modified CAR-T cells using virus-free gene-transfer technology based on
proof-of-concept work performed in preclinical and clinical studies at the University of
Würzburg. The project is pursuing technologically advanced CAR-T products with
SaxoCell Projects CURX GmbH and advanced clinical-grade manufacturing through Fraunhofer IZI.
therapeutic potential in hematology and oncology through the CAR-T biotech start-up T-
In the context of the SaxoCell future cluster, the value chain for such advanced CAR-T
products will be developed and exploited.
Project Manager: Prof. Dr. Michael Hudecek
Project Partners: Fraunhofer IZI, University Hospital Würzburg, University of Leipzig, T-
CURX GmbH
29
